Clinical Trials Sponsored by Otsuka Beijing Research Institute

Total 91 results

Otsuka Beijing Research Institute

Recruiting

PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

China
Otsuka Beijing Research Institute

Active, not recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia

China
Otsuka Beijing Research Institute

Completed

OPC-61815 in Healthy Chinese Male Subjects

Healthy Adult Male

China
Otsuka Beijing Research Institute

Terminated

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

Major Depressive Disorder

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Unknown

To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject

Severe Hypercholesterolemia

China
Otsuka Beijing Research Institute

Completed

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Singapore
Otsuka Beijing Research Institute

Completed

Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

Hyperlipidemia

China
Otsuka Beijing Research Institute

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Diabetic Nephropathy

China
Otsuka Beijing Research Institute

Completed

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Recruiting

Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Health

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder

China
Otsuka Beijing Research Institute

Completed

A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers

Chinese Healthy Volunteers

China
Otsuka Beijing Research Institute

Completed

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Type 2 Diabetes Mellitus | Arteriosclerosis Obliterans

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Recruiting

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

Open Angle Glaucoma or Ocular Hypertension

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

Tourette Syndrome

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema

Cardiac Edema

China
Otsuka Beijing Research Institute

Completed

Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

Atherosclerosis Cerebral Infarction

China
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

Hypovolemic Hyponatremia

China
Otsuka Beijing Research Institute
Zhejiang Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke

Cerebral Infarction

China
Otsuka Beijing Research Institute
Zhejiang Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia

Schizophrenia

China
Otsuka Frankfurt Research Institute GmbH

Completed

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Otsuka Frankfurt Research Institute GmbH

Unknown

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

SIADH | Non-SIADH Hyponatremia | Non-Hyponatremia

Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Otsuka Frankfurt Research Institute GmbH

Completed

ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

Ulcerative Colitis
Otsuka Frankfurt Research Institute GmbH

Completed

CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis

Ulcerative Colitis

Germany
Otsuka Frankfurt Research Institute GmbH

Completed

A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

Intermittent Claudication

Germany
Otsuka Frankfurt Research Institute GmbH

Completed

Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)

Ulcerative Colitis
Lawson Health Research Institute
Otsuka Pharmaceutical Co., Ltd.

Completed

The Effects of Cranberry Juice on Bacterial Adhesion

Bacterial Vaginosis | Oxaluria
Beijing HuiLongGuan Hospital
Stanley Medical Research Institute

Completed

Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia

Schizophrenia

China
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy
Beijing HuiLongGuan Hospital
Stanley Medical Research Institute

Completed

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Tardive Dyskinesia

China
Beijing HuiLongGuan Hospital
Stanley Medical Research Institute

Completed

A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

Schizophrenia

China
Beijing Institute of Technology
China Rehabilitation Research Center

Unknown

A Powered Ankle Foot Rehabilitation Orthosis

Stroke | Ankle Injuries

China
Memorial Sloan Kettering Cancer Center
Otsuka America Pharmaceutical; Ludwig Institute for Cancer Research

Completed

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Multiple Myeloma

United States
Beijing Jishuitan Hospital
National Institute for Nutrition and Health Chinese Center for Disease Control... and other collaborators

Completed

Bone Age of Chinese Child (BACC) (BACC)

Bone Development

China
Kaifeng Pharmaceutical (Group) Co., Ltd.
Beijing Furen Biomedical Research Institute Co., Ltd.

Unknown

A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Hemophilia A

China
Ottawa Hospital Research Institute
CSL Behring; Grifols Biologicals, LLC

Completed

Ig PRx in AECOPD: Pilot Study

Chronic Obstructive Pulmonary Disease

Canada
Bill & Melinda Gates Medical Research Institute
Global Alliance for TB Drug Development; Janssen Pharmaceutica; Otsuka Pharmaceutical...

Recruiting

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa, Philippines
Yale University
National Institute of Nursing Research (NINR); Beijing Ditan Hospital; Shanghai...

Completed

Self- and Family-management Intervention in HIV+ Chinese Women

Hiv

China

Clinical Trials Sponsored by Otsuka Beijing Research Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations